The North American Consortia for the Study of End Stage Liver Disease
Our Mission
Improve outcomes for inpatients and outpatients with cirrhosis across North America.
Why it Matters
Cirrhosis remains a major cause of morbidity and mortality across North
America but the determinants change over time.
All Consortia
ACTIVE
Started: June 2020
NACSELD 3
Multicenter cohort of outpatients
with cirrhosis with compensated
and decompensated cirrhosis
Started: October 2013
NACSELD 2
Multicenter cohort of patients
with cirrhosis hospitalized
non-electively
Started: November 2010